- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03540550
Effects of a Diet Based on Inulin-rich Vegetables on Gut Health and Nutritional Behaviour in Healthy Humans
Modification of the Gut Microbiota Following the Consumption of Inulin-rich Vegetables: Effect on Gut Tolerance, Transit, Behaviour and Digestion in Healthy Humans
Inulin-type fructans (ITF) are fermentable dietary fibres that can confer beneficial health effects through changes in the gut microbiota. However, their effect on gut sensitivity and nutritional behaviour is a matter of debate.
The investigators evaluated, in healthy individuals, the impact of shifting from their usual food habits towards a diet based on the daily consumption of ITF-rich vegetables on gut microbiota, gastro-intestinal symptoms and food-related behaviour.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI between 20 and 25 kg/m²
- Caucasian ethnicity
- Hydrogen producers (assessed by hydrogen breath test)
Exclusion Criteria:
- Smokers
- Laxative consumption (<4 weeks)
- Severe intestinal problems
- Psychiatric problems or use of antipsychotic
- Consumption of antibiotics, pro/prebiotics, fibre dietary supplement, or any molecules that modifies the intestinal transit (<6 weeks)
- Specific dietary practise (vegetarian, vegan,...)
- Specific dietary treatment (<6 weeks) (e.g. high protein diet)
- Excessive alcohol consumption (>3 glasses/day)
- Consumption of the following drugs: proton pump inhibitor, antidiabetic drugs, cholesterol lowering drugs
- Inconclusive acceptability test (regarding the protocol of the intervention and the vegetables used in the protocol)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary intervention
|
During two weeks, healthy subjects were instructed to adhere to a controlled diet based on ITF-rich vegetables (±15 g ITF/day).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gut microbiota composition
Time Frame: 33 days
|
Gut microbiota composition is assessed by 16S rRNA pyrosequencing.
This analysis allows to obtain the relative abundance (%) of the different bacterial taxa and OTUs (operational taxonomic units).
|
33 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gut microbiota fermentation in vivo
Time Frame: 33 days
|
Gut microbiota fermentation is assessed in vivo by an hydrogen breath test.
After an oral load of purified inulin, the level of expired hydrogen (ppm) is measured.
|
33 days
|
Gut microbiota fermentation in vitro
Time Frame: 14 days
|
Gut microbiota fermentation is assessed in vitro by the measurement of total gas (ml/g of dry matter) produced from subject feces incubated with inulin-rich substrates.
|
14 days
|
Gastrointestinal Symptoms
Time Frame: 33 days
|
Gastrointestinal symptoms were assessed by Visual Analogue Scale (horizontal line of 100 mm).
Each subject completed seven separate scales, one for each symptom (rumble, burp, bloating, discomfort, nausea, flatulence, cramp), ranging from "no sensation" (0 mm) to "very severe sensation" (100 mm).
|
33 days
|
Appetite-related feelings
Time Frame: 33 days
|
Appetite-related feelings were assessed by Visual Analogue Scale (horizontal line of 100 mm).
Each subject completed seven separate scales, one for each appetite-related feeling (satiety, intention to eat, fullness, sweet envy, very sweet envy, fat envy, salt envy), ranging from "no sensation" (0 mm or 100 mm depending on the feeling) , to "very strong sensation" (0 mm or 100 mm depending on the feeling).
|
33 days
|
Correlation of gastrointestinal symptoms with gut bacteria
Time Frame: 33 days
|
The levels of gastrointestinal symptoms were correlated (Spearman correlations) with the relative abundance of bacterial taxa and OTUs (operational taxonomic units)
|
33 days
|
Short chain fatty acids production
Time Frame: 14 days
|
Short chain fatty acids (SCFAs) production was assessed in vitro by the measurement of total SCFAs (mg/g of dry matter) produced from subject feces incubated with inulin-rich substrates.
|
14 days
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- B403201627275
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Diet based on inulin-rich vegetables
-
United Arab Emirates UniversityUnknownVisceral ObesityUnited Arab Emirates
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Texas Tech University Health Sciences CenterCompletedHealth BehaviorUnited States
-
Seoul National University HospitalChunLabUnknown
-
Federico II UniversityRecruitingObesity | Birth Weight | Breast Feeding | Gestational Weight Gain | Allergies | Chronic Diseases in Children | Gestational Complications | Perinatal ConditionItaly
-
University of Warmia and MazuryNational Science Centre, PolandCompletedFunctional Abdominal Pain SyndromePoland
-
University of SkövdeAlbert Einstein College of Medicine; Uppsala University; Göteborg University; University... and other collaboratorsNot yet recruitingObesity | Stress | Anxiety | Depressive Symptoms | Dysbiosis | Eating HabitSweden
-
Barbara Jakše s.p.CompletedObesity | Weight Loss
-
Qingdao UniversityNot yet recruitingHealthy | Diet | Gestational Diabetes Mellitus in PregnancyChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University Of Perugia; Azienda Ospedaliera Universitaria Policlinico Paolo... and other collaboratorsRecruiting